APA (7th ed.) Citation

Calvo, E., Porta, C., Escudier, B., Ravaud, A., Oudard, S., Osanto, S., . . . Motzer, R. (2010). 97 EVEROLIMUS (EVE) IN RECORD-1 ELDERLY PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC) AND MANAGEMENT OF RELATED ADVERSE EVENTS (AES). European Urology Supplements, 9(2), 63. https://doi.org/10.1016/S1569-9056(10)60103-0

Chicago Style (17th ed.) Citation

Calvo, E., et al. "97 EVEROLIMUS (EVE) IN RECORD-1 ELDERLY PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC) AND MANAGEMENT OF RELATED ADVERSE EVENTS (AES)." European Urology Supplements 9, no. 2 (2010): 63. https://doi.org/10.1016/S1569-9056(10)60103-0.

MLA (9th ed.) Citation

Calvo, E., et al. "97 EVEROLIMUS (EVE) IN RECORD-1 ELDERLY PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC) AND MANAGEMENT OF RELATED ADVERSE EVENTS (AES)." European Urology Supplements, vol. 9, no. 2, 2010, p. 63, https://doi.org/10.1016/S1569-9056(10)60103-0.